Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Deleted the disease term 'Multiple Myeloma' from the page and removed the Related Topic 'MedlinePlus Genetics'. This could reduce clarity about the study's focus and remove an external educational resource, while most other study content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-05T17:29:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:47:28.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:32:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added related-topic links for 'Multiple myeloma' and 'MedlinePlus Genetics' on the Study Details page to provide quick access to background information. No changes to study data or user workflows were made.
    Difference
    0.1%
    Check dated 2026-02-28T14:00:27.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Removed related topics 'Multiple Myeloma' and 'MedlinePlus Genetics' from the page's related topics.
    Difference
    0.1%
    Check dated 2026-02-21T10:18:58.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    New topic tags 'Multiple myeloma' and a related topic 'MedlinePlus Genetics' were added, and the page revision updated from v3.4.1 to v3.4.2. These changes are metadata-level and do not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T05:53:21.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.